Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Judy Un Chong Ahrar Image

      Judy Un Chong Ahrar, MD

      Department of Interventional Radiology, Division of Diagnostic Imaging

      About Dr. Ahrar

      Dr. Judy Ahrar is a Professor of Interventional Radiology at UTMD Anderson Cancer Center. Dr. Ahrar received her Doctorate in Medicine from the University of Miami in 2000. Currently, Dr. Ahrar serves as the Physician Liaison for the Diagnostic Imaging Professional Quality Committee since 2007, Representative for Clinical Safety and Effectiveness Committee since 2013 and Alternative Representative for the Credentials Committee since 2013. Dr. Ahrar began her medical career at UTMD Anderson Cancer Center in 2006 as an Assistant Professor in Diagnostic Radiology and was promoted to Associate Professor in 2012. Her first experience with clinical trials was during her fellowship training at the University of Texas and reflects over 14 years of direct Clinical and Research experience with the University of Texas. Her research and clinical interests are Image guided biopsy, Lung and Mediastinum biopsy, Chemoembolization of the liver and Quality Improvement.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

      Assistant Professor, Department of Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX

      Research Interests

      Image guided biopsy, Lung and Mediastinum biopsy, Chemoembolization of the liver and Quality Improvement

      Education & Training

      Degree-Granting Education

      2000University of Miami, Miami, Florida, US, MD
      1996University of Miami, Coral Gables, Florida, US, Biology, BS

      Postgraduate Training

      2005-2006Clinical Fellowship, Interventional Radiology, The University of Texas Medical School at Houston, Houston, Texas
      2001-2005Clinical Residency, Diagnostic Radiology, The University of Texas Health Science Center, Houston, Texas
      2000-2001Clinical Internship, Internal Medicine, New Hanover Regional Medical Center, Wilmington, North Carolina

      Licenses & Certifications

      2023Advanced Cardiovascular Life Support
      2022DEA
      2007American Board of Radiology, Interventional Radiology/Diagnostic Radiology
      2006Texas Medical Board
      2005American Board of Radiology

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2018

      Associate Professor, Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2013

      Assistant Professor, Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2012

      Administrative Appointments/Responsibilities

      Epic Certified Physician Builder, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016

      Intramural Institutional Committee Activities

      Member, Specimen Source Governance Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, Perioperative Informatics Subcommittee, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, Department of Anesthesiology Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2020

      Member, DI Informatics Functional Committee, The University of Texas MD Anderson Cancer Center, 2015 - Present

      Provider Officer, EPIC Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present

      Representative, Clinical Safety and Effectiveness Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present

      Representative/ Alternative, Credentials Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present

      Professional Physician Liaison, Professional Quality Committee, The University of Texas MD Anderson Cancer Center, 2007 - Present

      Honors & Awards

      2017Excellence in OneConnect Leadership, President's Faculty Recognition - The University of Texas MD Anderson Cancer Center

      Professional Memberships

      Texas Radiological Society

      2007 - Present

      American College of Radiology

      2007 - Present

      Western Angiographic and Interventional Society

      2007 - Present

      Society of Interventional Radiology

      2005 - Present

      Texas Medical Association

      2001 - Present

      Harris County Medical Society

      2001 - Present

      Radiological Society of North America (RSNA)

      2001 - Present

      American Medical Association

      1996 - Present

      Grant & Contract Support

      Date: 2011 - 2016
      Title:Phase 1b, escalating dose study of AVL-292, a Bruton's Tyrosine Kimase (BtK) inhibitor, as monotherapy subjects with relapsed and/or refractory B cell Non-Hodgkin Lymphoma, chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
      Funding Source:Celgene Corporation
      Role:Collaborator
      ID:2011-0513
      Date: 2010 - 2013
      Title:A phase 1b open-label, expansion study to investigate the safety, efficacy, and pharmacokinetics of intravenous CUDC-101 in subjects with advanced head and neck, gastric, breast, and liver tumors
      Funding Source:Curis, Inc
      Role:Collaborator
      ID:2010-0483
      Date: 2008 - 2012
      Title:A study to determine correlation of MR thermal imaging to actual size of ablation during laser therapy of soft tissue metastases to bone
      Funding Source:BioTex, Inc
      Role:Collaborator
      ID:2007-0393
      Date: 2008 - 2011
      Title:A phase I/II, open label, multi-centre study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of the Tor Kinase inhibitors AZD8055 administered orally to patients with advanced solid tumors, lymphomas and endometrial carcinoma
      Funding Source:AstraZeneca
      Role:Collaborator
      ID:2008-0228
      Date: 2006 - 2014
      Title:Enhanced T-cell immunity to novel breast cancer antigens
      Funding Source:Susan G. Komen Breast Cancer Foundation
      Role:Collaborator
      ID:LAB05-0680
      Date: 2006 - 2011
      Title:A phase II study of SGN-30 in combination with CHOP in anaplastic large cell lymphoma
      Funding Source:SAIC-Frederick, Inc
      Role:Collaborator
      ID:2005-0627

      Selected Publications

      Peer-Reviewed Articles

      1. Awad A, Ahrar J, Abdelsalam ME. Cystoscope assisted trans-conduit removal of fragmented percutaneous nephrostomy catheter. Urol Case Rep 62:103176, 2025. e-Pub 2025. PMID: 40919173.
      2. Pal K, Patel M, Chen SR, Odisio B, Metwalli Z, Ahrar J, Irwin D, Sheth RA, Kuban JD. A Single-center Experience with a Shear Thinning Conformable Embolic. J Vasc Interv Radiol 35(8):1215-1220, 2024. e-Pub 2024. PMID: 38719091.
      3. de Groot PM, Shroff GS, Ahrar J, Sabloff BS, Gladish GM, Moran C, Gupta S, Gladish GW, Chang JY, Erasmus JJ. Implications for high-precision dose radiation therapy planning or limited surgical resection after percutaneous computed tomography-guided lung nodule biopsy using a tract sealant. Adv Radiat Oncol 3(2):139-145, 2018. e-Pub 2018. PMID: 29904738.
      4. Litwin RJ, Huang SY, Sabir SH, Hoang QB, Ahrar K, Ahrar J, Tam AL, Mahvash A, Ensor JE, Kroll M, Gupta S. Impact of an inferior vena cava filter retrieval algorithm on filter retrieval rates in a cancer population. J Vasc Surg Venous Lymphat Disord 5(5):689-697, 2017. e-Pub 2017. PMID: 28818223.
      5. Gupta N, Patel A, Ensor J, Ahrar K, Ahrar J, Tam A, Odisio B, Huang S, Murthy R, Mahvash A, Avritscher R, McRae S, Sabir S, Wallace M, Matin S, Gupta S. Multiple Renal Artery Pseudoaneurysms in Patients Undergoing Renal Artery Embolization Following Partial Nephrectomy: Correlation with RENAL Nephrometry Scores. Cardiovasc Intervent Radiol 40(2):202-209, 2017. e-Pub 2017. PMID: 27681271.
      6. Ahrar JU, Gupta S, Ensor JE, Mahvash A, Sabir SH, Steele JR, McRae SE, Avritscher R, Huang SY, Odisio BC, Murthy R, Ahrar K, Wallace MJ, Tam AL. Efficacy of a Self-expanding Tract Sealant Device in the Reduction of Pneumothorax and Chest Tube Placement Rates After Percutaneous Lung Biopsy: A Matched Controlled Study Using Propensity Score Analysis. Cardiovasc Intervent Radiol 40(2):270-276, 2017. e-Pub 2017. PMID: 27826786.
      7. McWilliams JP, Shah RP, Quirk M, White SB, Dybul SL, Ahrar J, Steele JR, Kwan SW, Handel J, Winokur RS, Gilliland CA, Durack JC. Standardized Reporting in IR: A Prospective Multi-Institutional Pilot Study. J Vasc Interv Radiol 27(12):1779-1785, 2016. e-Pub 2016. PMID: 27670943.
      8. Kuban JD, Tam AL, Huang SY, Ensor JE, Philip AS, Chen GJ, Ahrar J, Murthy R, Avritscher R, Madoff DC, Mahvash A, Ahrar K, Wallace MJ, Nachiappan AC, Gupta S. The Effect of Needle Gauge on the Risk of Pneumothorax and Chest Tube Placement After Percutaneous Computed Tomographic (CT)-Guided Lung Biopsy. Cardiovasc Intervent Radiol 38(6):1595-602, 2015. e-Pub 2015. PMID: 25920917.
      9. Ahrar K, Ahrar JU, Javadi S, Pan L, Milton DR, Wood CG, Matin SF, Stafford RJ. Real-time magnetic resonance imaging-guided cryoablation of small renal tumors at 1.5 T. Invest Radiol 48(6):437-44, 2013. e-Pub 2013. PMID: 23511191.
      10. Ahrar JU, Stafford RJ, Alzubaidi S, Ahrar K. Magnetic resonance imaging-guided biopsy in the musculoskeletal system using a cylindrical 1.5-T magnetic resonance imaging unit. Top Magn Reson Imaging 22(4):189-96, 2011. e-Pub 2011. PMID: 23514926.
      11. Ahrar J, Gupta S, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P, Bedikian AY. Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Invest 29(1):49-55, 2011. e-Pub 2011. PMID: 21166498.
      12. Gupta S, Bedikian AY, Ahrar J, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors. Am J Clin Oncol 33(5):474-480, 2010. e-Pub 2010. PMID: 19935383.
      13. Javadi J, Ahrar JU, Ninan E, Gupta S, Matin S, Ahrar K. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors. J Vasc Interv Radiol 21(5):690-695, 2010. e-Pub 2010. PMID: 20227295.
      14. Ahrar K, Gowda A, Javadi S, Borne A, Fox M, McNichols R, Ahrar JU, Stephens C, Stafford RJ. Preclinical assessment of a 980-nm diode laser ablation system in a large animal tumor model. J Vasc Interv Radiol 21(4):555-561, 2010. e-Pub 2010. PMID: 20346883.
      15. Ahrar K, Himmerich JU, Herzog CE, Raymond AK, Wallace MJ, Gupta S, Madoff DC, Morello FA, Murthy R, McRae SE, Hicks ME. Percutaneous ultrasound-guided biopsy in the definitive diagnosis of osteosarcoma. J Vasc Interv Radiol 15(11):1329-1333, 2004. e-Pub 2004. PMID: 15525755.

      Review Articles

      1. Ahrar K, Sabir SH, Yevich SM, Sheth RA, Ahrar JU, Tam AL, Stafford JR. MRI-Guided Interventions in Musculoskeletal System. Top Magn Reson Imaging 27(3):129-139, 2018. e-Pub 2018. PMID: 29870465.

      Professional Educational Materials

      1. Himmerich JU, Ahrar K. Palliation of bone and soft tissue tumors with RFA. Interventional Oncology: Current practice and future trends. Manual for Conference sponsored by the Society of Interventional Radiology, 2003.

      Abstracts

      1. Sabir S, Patel R, Lin B, Ahrar J, Tam A, Ahrar K. Enhancing the care of cancer patients with ureteral strictures managed with percutaneous nephrostomy tubes. Cancer Survivorship Symposium: Advancing Care and Research 34(3s), 2016. e-Pub 2016.
      2. Ahrar J, Ensor J, Mahvash A, Sabir S, Steele J, McRae S, Avritscher R, Huang S, Odisio B, Murthy R, Ahrar K, Wallace M, Gupta S. Efficacy of a self-expanding tract sealant device in the reduction of pneumothorax and chest tube placement rates after percutaneous lung biopsy: a matched controlled study using propensity score analysis. Society of Interventional Radiology 2015 Annual Scientific Meeting 26(2S):S149-S150, 2015. e-Pub 2015.
      3. Huynh T, Huang S, Ahrar J, Mehran R, Ahrar K. Contemporary management of radiation-induced llio-femoral arterial occlusive disease in a cancer survivors. Society for Clinical Vascular Surgery 42nd Annual Symposium, 2014. e-Pub 2014.
      4. Smith JG, Ahrar K, Huynh TT, Wallace MJ, Ahrar JU. Vascular Emergencies in Cancer Patients,. Radiological Society of North America 99th Scientific Assembly and Annual Meeting, 2013. e-Pub 2013.
      5. Gupta N, Patel AA, Ahrar K, Ahrar JU, Tam AL, Wallace MJ, Gupta S. Transarterial embolization of renal artery pseudoaneurysms following partial nephrectomy. Radiological Society of North America 99th Scientific Assembly and Annual Meeting, 2013. e-Pub 2013.
      6. Ahrar K, Ahrar JU, Javadi S, Pan L, Milton D, Wood CG, Matin SF, Stafford RJ. Real-time MRI guided cryoablation of small renal tumors at 1.5 tesla. Global Academic Programs, 2013. e-Pub 2013.
      7. Ahrar JU, Stafford RJ, Alzubaidi S, Ahrar K. MRI-guided biopsy in the musculoskeletal system using a cylindrical 1.5-T MRI unit. Global Academic Programs, 2013. e-Pub 2013.
      8. Alzubaidi S, Ahrar JU, Javadi S, Gupta S, Stafford RJ, Ahrar K. MRI-guided biopsy using a cylindrical high-field-strength magnet: experience with 303 biopsies in 294 patients. Society of Interventional Radiology 2013 Annual Scientific Meeting 24(4S):S96, 2013. e-Pub 2013.
      9. Kuban JD, Philip AS, Chen GJ, Joseph Jr E, Tam A, Wallace MJ, Avritscher R, Ahrar JU, Ahrar K, Murthy R, Mahvash A, McRae S, Gupta S. Effect of needle size on pneumothorax and chest tube placement rates in CT-guided percutaneous lung biopsies performed using a coaxial method: a large single-center study. Society of Interventional Radiology 2012 Annual Scientific Meeting 23(3S):S27-S28, 2012. e-Pub 2012.
      10. Javadi S, Stafford RJ, Ahrar JU, Gupta S, Wallace MJ, Pan L, Ahrar K. Real-time MR-guided percutaneous interventions in a dedicated 1.5T clinical suite. International Society for Magnetic Resonance in Medicine 2009:2554, 2009. e-Pub 2009.
      11. Javadi S, Ahrar JU, Ninan EP, Gupta S, Matin SF, Ahrar K. Renal tumors continue to accumulate iodinated contrast in the immediate post-RFA period. Society of Interventional Radiology 2009 Annual Scientific Meeting 20(2S):S8, 2009. e-Pub 2009.
      12. Javadi S, Ahrar JU, Stafford RJ, Bock M, Jenna JW, Ahrar K. MRI-guided tumor ablation at high magnetic field: technologies, devices, advantages and limitations. Society of Interventional Radiology 2009 Annual Scientific Meeting 20(2S):S114, 2009. e-Pub 2009.
      13. Ahrar JU, Javadi S, Valenzuela Y, Gupta S, Stafford R, Ahrar K. MRI guided biopsy using a high field strength magnet: Initial experience with 95 patients. 94th Radiological Society of North America Scientific Assembly and Annual Meeting Program, 2008. e-Pub 2008.
      14. Javadi S, Ahrar JU, Gupta S, Wallace MJ, Matin SF, Ahrar K. Embolotherapy in the management of patients with renal cell carcinoma: Current indications, technical considerations, and complications. 93rd Radiological Society of North America Scientific Assembly and Annual Meeting Program, 2007. e-Pub 2007.
      15. Javadi S, Stafford RJ, Ahrar JU, Gowda A, McNichols R, Ahrar K. Principles of laser induced thermal therapy. 93rd Radiological Society of North America Scientific Assembly and Annual Meeting Program, 2007. e-Pub 2007.
      16. Ahrar JU, Gupta S, Ensor J, Ahrar K, Madoff DC, Wallace MJ. Response and survival after hepatic artery chemoembolization in patients with melanomas metastatic to the liver. J Vasc Interv Radiol 18(1S):S57, 2007. e-Pub 2007.
      17. Himmerich JU, Ahrar K, Wang S, Gupta S, Raymond A, Herzog C. Utility of ultrasound-guided percutaneous biopsy in the definitive diagnosis of osteosarcoma. Society of Interventional Radiology 2004 Annual Scientific Meeting 15(2S):S231, 2004. e-Pub 2004.
      18. Himmerich JU, Ahrar K, Gupta S, Wallace MJ, Madoff DC, Morello FA. Intra-arterial chemotherapy for osteosarcoma: Indications, technique, and complications. Radiology 229:763, 2003. e-Pub 2003.

      Book Chapters

      1. Metwalli Z, Ahrar JU, Wallace M. Interventional Radiology for the Cancer Patient. In: Cancer Medicine. John Wiley & Sons, Inc, 2022.
      2. Ahrar K, Javadi S, Ahrar JU. Renal Mass Biopsy. In: Percutaneous Image-Guided Biopsy. Springer Science+Business Media, 2013.
      3. Ahrar JU, Ahrar K. Ultrasound-Guided Biopsy. In: Percutaneous Image-Guided Biopsy. Springer Science+Business Media, 2013.
      4. Ahrar JU, Javadi S, Ahrar K. Percutaneous and Transjugular Kidney Biopsy. In: Percutaneous Image-Guided Biopsy. Springer Science+Business Media, 2013.

      Books (edited and written)

      1. Ahrar J. Cancer Medicine, 2015.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 20, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top